BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring. BD Advanced Patient Monitoring is a global leader in advanced monitoring solutions that expands BD’s portfolio of smart connected care solutions with its growing set of leading monitoring technologies, advanced AI-enabled clinical decision tools and robust innovation pipeline. BD Advanced Patient Monitoring’s technologies are often used simultaneously with the BD Alaris™ Infusion System in the operating room or intensive care units.
Read the full article: BD Completes Acquisition of Critical Care from Edwards Lifesciences //
Source: https://www.prnewswire.com/news-releases/bd-completes-acquisition-of-critical-care-from-edwards-lifesciences-302237204.html